Cargando…
Immunotherapy for cancer in the central nervous system: Current and future directions
Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and still remains incurable. Although immunotherapeutic vaccination against GBM has demonstrated immune-stimulating activity with some promising survival benefits, tumor relapse is common, highlighting the need for additi...
Autores principales: | Binder, David C., Davis, Andrew A., Wainwright, Derek A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801467/ https://www.ncbi.nlm.nih.gov/pubmed/27057463 http://dx.doi.org/10.1080/2162402X.2015.1082027 |
Ejemplares similares
-
Current application and future directions of photobiomodulation in central nervous diseases
por: Yang, Muyue, et al.
Publicado: (2020) -
Systemic Immunotherapy for Urothelial Cancer: Current Trends and Future Directions
por: Gupta, Shilpa, et al.
Publicado: (2017) -
Current status and future directions of cancer immunotherapy
por: Zhang, Hongming, et al.
Publicado: (2018) -
Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions
por: Bryant, John Michael, et al.
Publicado: (2023) -
The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors
por: Rodriguez, Andrew, et al.
Publicado: (2023)